Search Results - Véronique Mathieu

Refine Results
  1. 1
    A review of the current status of siRNA nanomedicines in the treatment of cancer

    A review of the current status of siRNA nanomedicines in the treatment of cancer by Pauline Resnier, Tristan Montier, Véronique Mathieu, Jean‐Pierre Benoît, Catherine Passirani

    Published 2013
    Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Galectins and Gliomas

    Galectins and Gliomas by Marie Le Mercier, Shannon P. Fortin Ensign, Véronique Mathieu, Róbert Kiss, Florence Lefranc

    Published 2009
    Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Sesterterpenoids with Anticancer Activity

    Sesterterpenoids with Anticancer Activity by Antonio Evidente, Alexander Kornienko, Florence Lefranc, Alessio Cimmino, Ramesh Dasari, Marco Evidente, Véronique Mathieu, Róbert Kiss

    Published 2015
    Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Galectin-1 Knockdown Increases Sensitivity to Temozolomide in a B16F10 Mouse Metastatic Melanoma Model

    Galectin-1 Knockdown Increases Sensitivity to Temozolomide in a B16F10 Mouse Metastatic Melanoma Model by Véronique Mathieu, Marie Le Mercier, Nancy De Nève, Sébastien Sauvage, Thierry Gras, Isabelle Roland, Florence Lefranc, Róbert Kiss

    Published 2007
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Knocking Down Galectin 1 in Human Hs683 Glioblastoma Cells Impairs Both Angiogenesis and Endoplasmic Reticulum Stress Responses

    Knocking Down Galectin 1 in Human Hs683 Glioblastoma Cells Impairs Both Angiogenesis and Endoplasmic Reticulum Stress Responses by Marie Le Mercier, Véronique Mathieu, Benjamin Haibe‐Kains, Gianluca Bontempi, Tatjana Mijatovic, Christine Decaestecker, Róbert Kiss, Florence Lefranc

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?

    Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM? by Matthias Van Woensel, Nathalie Wauthoz, Rémi Rosière, Karim Amighi, Véronique Mathieu, Florence Lefranc, Stefaan Van Gool, Steven De Vleeschouwer

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Combining Bevacizumab with Temozolomide Increases the Antitumor Efficacy of Temozolomide in a Human Glioblastoma Orthotopic Xenograft Model

    Combining Bevacizumab with Temozolomide Increases the Antitumor Efficacy of Temozolomide in a Human Glioblastoma Orthotopic Xenograft Model by Véronique Mathieu, Nancy De Nève, Marie Le Mercier, Janique Dewelle, Jean‐François Gaussin, Mischaël Dehoux, Róbert Kiss, Florence Lefranc

    Published 2008
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    A harmine-derived beta-carboline displays anti-cancer effects in vitro by targeting protein synthesis

    A harmine-derived beta-carboline displays anti-cancer effects in vitro by targeting protein synthesis by Annelise Carvalho, Jennifer Chu, Céline Meinguet, Róbert Kiss, Guy Vandenbussche, Bernard Masereel, Johan Wouters, Alexander Kornienko, Jerry Pelletier, Véronique Mathieu

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Cardenolide-Induced Lysosomal Membrane Permeabilization Demonstrates Therapeutic Benefits in Experimental Human Non-Small Cell Lung Cancers

    Cardenolide-Induced Lysosomal Membrane Permeabilization Demonstrates Therapeutic Benefits in Experimental Human Non-Small Cell Lung Cancers by Tatjana Mijatovic, Véronique Mathieu, Jean‐François Gaussin, Nancy De Nève, Fabrice Ribaucour, Eric Van Quaquebeke, Patrick Dumont, Francis Darro, Róbert Kiss

    Published 2006
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Aggressiveness of human melanoma xenograft models is promoted by aneuploidy-driven gene expression deregulation

    Aggressiveness of human melanoma xenograft models is promoted by aneuploidy-driven gene expression deregulation by Véronique Mathieu, Christine Pirker, Wolfgang M. Schmidt, Sabine Spiegl‐Kreinecker, Daniela Lötsch, Petra Heffeter, Balázs Hegedűs, Michael Grusch, Róbert Kiss, Walter Berger

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Toward a Cancer Drug of Fungal Origin

    Toward a Cancer Drug of Fungal Origin by Alexander Kornienko, Antonio Evidente, Maurizio Vurro, Véronique Mathieu, Alessio Cimmino, Marco Evidente, Willem A. L. van Otterlo, Ramesh Dasari, Florence Lefranc, Róbert Kiss

    Published 2015
    Get full text
    Revisão
    Save to List
    Saved in:
  12. 12
    Ophiobolin A induces paraptosis-like cell death in human glioblastoma cells by decreasing BKCa channel activity

    Ophiobolin A induces paraptosis-like cell death in human glioblastoma cells by decreasing BKCa channel activity by Marina Bury, Alban Girault, Véronique Mégalizzi, Sabine Spiegl‐Kreinecker, Véronique Mathieu, Walter Berger, Antonio Evidente, Alexander Kornienko, Philippe Gailly, Christophe Vandier, Róbert Kiss

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Tumor Cells Secrete Galectin-1 to Enhance Endothelial Cell Activity

    Tumor Cells Secrete Galectin-1 to Enhance Endothelial Cell Activity by Victor L. Thijssen, Batya Barkan, Hiroki Shoji, Ingrid M. Ariës, Véronique Mathieu, Louise Deltour, Tilman M. Hackeng, Róbert Kiss, Yoel Kloog, Françoise Poirier, Arjan W. Griffioen

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Galectin 1 Proangiogenic and Promigratory Effects in the Hs683 Oligodendroglioma Model Are Partly Mediated through the Control of BEX2 Expression

    Galectin 1 Proangiogenic and Promigratory Effects in the Hs683 Oligodendroglioma Model Are Partly Mediated through the Control of BEX2 Expression by Marie Le Mercier, Shannon P. Fortin Ensign, Véronique Mathieu, Isabelle Roland, Sabine Spiegl‐Kreinecker, Benjamin Haibe‐Kains, Gianluca Bontempi, Christine Decaestecker, Walter Berger, Florence Lefranc, Róbert Kiss

    Published 2009
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Fungal metabolite ophiobolin A as a promising anti-glioma agent: In vivo evaluation, structure–activity relationship and unique pyrrolylation of primary amines

    Fungal metabolite ophiobolin A as a promising anti-glioma agent: In vivo evaluation, structure–activity relationship and unique pyrrolylation of primary amines by Ramesh Dasari, Marco Masi, Romana Lisy, Marlène Ferdérin, Lance R. English, Alessio Cimmino, Véronique Mathieu, Andrew Brenner, John G. Kuhn, Steven T. Whitten, Antonio Evidente, Róbert Kiss, Alexander Kornienko

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Sphaeropsidin A shows promising activity against drug-resistant cancer cells by targeting regulatory volume increase

    Sphaeropsidin A shows promising activity against drug-resistant cancer cells by targeting regulatory volume increase by Véronique Mathieu, Aurélie Chantôme, Florence Lefranc, Alessio Cimmino, Walter Miklos, Verena Paulitschke, Thomas Mohr, Lucia Maddau, Alexander Kornienko, Walter Berger, Christophe Vandier, Antonio Evidente, Eric Delpire, Róbert Kiss

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Glioma‐derived galectin‐1 regulates innate and adaptive antitumor immunity

    Glioma‐derived galectin‐1 regulates innate and adaptive antitumor immunity by Tina Verschuere, Jaan Toelen, Wim Maes, Françoise Poirier, Louis Boon, Thomas Tousseyn, Thomas Mathivet, Holger Gerhardt, Véronique Mathieu, Róbert Kiss, Florence Lefranc, Stefaan W. Van Gool, Steven De Vleeschouwer

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    4-IBP, a σ1 Receptor Agonist, Decreases the Migration of Human Cancer Cells, Including Glioblastoma Cells, In Vitro and Sensitizes Them In Vitro and In Vivo to Cytotoxic Insults of Proapoptotic and Proautophagic Drugs

    4-IBP, a σ1 Receptor Agonist, Decreases the Migration of Human Cancer Cells, Including Glioblastoma Cells, In Vitro and Sensitizes Them In Vitro and In Vivo to Cytotoxic Insults of... by Véronique Mégalizzi, Véronique Mathieu, Tatjana Mijatovic, Philippe Gailly, Olivier Debeir, Nancy De Nève, Marc Van Damme, Gianluca Bontempi, Benjamin Haibe‐Kains, Christine Decaestecker, Yasuko Kondo, Róbert Kiss, Florence Lefranc

    Published 2007
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Higginsianins A and B, Two Diterpenoid α-Pyrones Produced by <i>Colletotrichum higginsianum</i>, with <i>in Vitro</i> Cytostatic Activity

    Higginsianins A and B, Two Diterpenoid α-Pyrones Produced by <i>Colletotrichum higginsianum</i>, with <i>in Vitro</i> Cytostatic Activity by Alessio Cimmino, Véronique Mathieu, Marco Masi, Riccardo Baroncelli, Angela Boari, Gennaro Pescitelli, Marlène Ferdérin, Romana Lisy, Marco Evidente, Angela Tuzi, Maria Chiara Zonno, Alexander Kornienko, Róbert Kiss, Antonio Evidente

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy

    Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy by Matthias Van Woensel, Thomas Mathivet, Nathalie Wauthoz, Rémi Rosière, Abhishek D. Garg, Patrizia Agostinis, Véronique Mathieu, Róbert Kiss, Florence Lefranc, Louis Boon, Jochen Belmans, Stefaan Van Gool, Holger Gerhardt, Karim Amighi, Steven De Vleeschouwer

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: